Expression of human papillomavirus type16 late gene (L1) in prokaryotic cells and its immune effict observation

LIU Chao-Qi,XU Xue-Mei,XU Jian-Qing
DOI: https://doi.org/10.3969/j.issn.1001-4411.2007.35.046
2007-01-01
Abstract:Objective:Human papillomavirus type16 vaccine is expected to prevent and cure cervical cancer.In the research,expect to prepare the preventive vaccine of HPV16 of Chinese population by cloning L1 gene from infected crowd in China.Methods:The HPV 16 L1 gene was amplified by PCR from HPV16 positive condyloma acuminata clinical samples,then cloned,sequenced and expressed L1 protein in prokaryotic cells.The recombinant protein was purified and re-natured.VLP was identified with electronic microscopy.Finally immunized animals and observed the production of antibody.Results:The L1 gene sequencing was as following:Four of the point mutations were C-G,nt6432 A→G、nt6901~03 and nt6951~53 in nt6240.The L1 gene was inserted into prokaryote expression vector pET-28a(+).The protein was identified by Western blot.Purified protein after reannealing could self-assemble VLP,and could elicit high titers specific antibody in immunized animals.Conclusion:HPV16 L1 gene has been cloned from clinical samples,sequenced,expressed and self-assembled into VLP,which has a good immunogenicity.It makes a foundation for prophylactic vaccine of HPV16.
What problem does this paper attempt to address?